98 related articles for article (PubMed ID: 14601011)
1. Methods for mid-course corrections in clinical trials with survival outcomes.
Cook TD
Stat Med; 2003 Nov; 22(22):3431-47. PubMed ID: 14601011
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial optimization: Monte Carlo simulation Markov model for planning clinical trials recruitment.
Abbas I; Rovira J; Casanovas J
Contemp Clin Trials; 2007 May; 28(3):220-31. PubMed ID: 16979387
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous group sequential analysis of rank-based and weighted Kaplan-Meier tests for paired censored survival data.
Andrei AC; Murray S
Biometrics; 2005 Sep; 61(3):715-20. PubMed ID: 16135022
[TBL] [Abstract][Full Text] [Related]
4. Bayesian model selection: analysis of a survival model with a surviving fraction.
Seltman H; Greenhouse J; Wasserman L
Stat Med; 2001 Jun; 20(11):1681-91. PubMed ID: 11391695
[TBL] [Abstract][Full Text] [Related]
5. Randomized trials and registries: a computer simulation to study the impact of surgeon/patient factors on outcomes.
Weiner BK; Patel R; Noble P
Spine J; 2008; 8(6):959-67. PubMed ID: 18243058
[TBL] [Abstract][Full Text] [Related]
6. Sample sizes for clinical trials with time-to-event endpoints and competing risks.
Schulgen G; Olschewski M; Krane V; Wanner C; Ruf G; Schumacher M
Contemp Clin Trials; 2005 Jun; 26(3):386-96. PubMed ID: 15911472
[TBL] [Abstract][Full Text] [Related]
7. Randomized trials for the real world: making as few and as reasonable assumptions as possible.
Baker SG; Kramer BS
Stat Methods Med Res; 2008 Jun; 17(3):243-52. PubMed ID: 17925312
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness as an outcome in randomized clinical trials.
Hlatky MA; Owens DK; Sanders GD
Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
[TBL] [Abstract][Full Text] [Related]
10. Estimating a treatment effect in survival studies in which patients switch treatment.
Branson M; Whitehead J
Stat Med; 2002 Sep; 21(17):2449-63. PubMed ID: 12205692
[TBL] [Abstract][Full Text] [Related]
11. Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology.
Nelson CL; Sun JL; Tsiatis AA; Mark DB
Stat Med; 2008 Nov; 27(26):5525-55. PubMed ID: 18613251
[TBL] [Abstract][Full Text] [Related]
12. Implementing a decision-theoretic design in clinical trials: why and how?
Palmer CR; Shahumyan H
Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
Salim A; Mackinnon A; Griffiths K
Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
[TBL] [Abstract][Full Text] [Related]
14. Improving the design of phase II trials of cytostatic anticancer agents.
Stone A; Wheeler C; Barge A
Contemp Clin Trials; 2007 Feb; 28(2):138-45. PubMed ID: 16843736
[TBL] [Abstract][Full Text] [Related]
15. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
Sheng D; Kim MY
Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
[TBL] [Abstract][Full Text] [Related]
16. Throw away the aspirin and take nonsteroidal anti-inflammatory drugs for the primary prevention of myocardial infarction.
Eliasziw M; Hill MD
Circulation; 2004 Feb; 109(7):e65-6; author reply e65-6. PubMed ID: 14981016
[No Abstract] [Full Text] [Related]
17. Design and analysis issues for economic analysis alongside clinical trials.
Marshall DA; Hux M
Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
[TBL] [Abstract][Full Text] [Related]
18. Use of simulation to compare the performance of minimization with stratified blocked randomization.
Toorawa R; Adena M; Donovan M; Jones S; Conlon J
Pharm Stat; 2009; 8(4):264-78. PubMed ID: 18756580
[TBL] [Abstract][Full Text] [Related]
19. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
[TBL] [Abstract][Full Text] [Related]
20. Design paper: the DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of aerobic versus non-aerobic versus relaxation training for patients with light to moderate depression.
Krogh J; Petersen L; Timmermann M; Saltin B; Nordentoft M
Contemp Clin Trials; 2007 Jan; 28(1):79-89. PubMed ID: 16935032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
